Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy.
about
Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapyThe role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage diseaseThe Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.Current role of FDG PET/CT in lymphoma.The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis.Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy.The role of FDG-PET in Hodgkin lymphomaUnproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.The predictive value of interim FDG-PET in early-stage Hodgkin lymphoma is not well established.Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma".Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?Hodgkin lymphoma: is there really a need for interim and end-of-treatment FDG-PET evaluations?
P2860
Q26781731-3C639C5C-6B99-4EC1-BAE3-9BD3F485457FQ26858893-7C5109F7-7672-4314-B4D0-3B629E07232DQ33778385-E6B45F1E-F633-4679-9062-673399933589Q37176540-57EA19D7-781E-4C0D-AF3B-E938108B0EFDQ38187365-7233CB2C-E96D-46B0-9456-D618BCCDB597Q38365591-276B3961-26E2-40AE-890D-6EA85B5F7B2FQ38418605-06BB2502-C5E0-4F6B-8A45-FF4270550C44Q39213429-C5CC976C-BB20-4B21-B64F-6C0801516CBDQ41691698-C241AF30-4587-456B-8FF6-1E027AD338D0Q48127652-29CB0C92-8E59-45DF-A75E-A2838C82E931Q50089452-CB7A300B-1498-4272-BDF9-7536947CE4D9Q52937933-369C9466-DCAE-471B-91AF-E1B1CF04B20EQ52984779-E979B869-6A3F-4C61-B2D6-7B400DD92C1AQ54192790-16ED4CEC-7F18-467E-8E16-19607818898C
P2860
Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Interim positron emission tomo ...... ith combined modality therapy.
@en
type
label
Interim positron emission tomo ...... ith combined modality therapy.
@en
prefLabel
Interim positron emission tomo ...... ith combined modality therapy.
@en
P2093
P2860
P50
P1433
P1476
Interim positron emission tomo ...... with combined modality therapy
@en
P2093
Alessandro Levis
Angela Botticella
Anna Castiglione
Barbara Botto
Daniela Gottardi
Gianni Bisi
Guido Parvis
Marilena Bellò
Paolo Gavarotti
P2860
P304
P356
10.3109/10428194.2012.735667
P577
2012-11-01T00:00:00Z